Exploiting Tumor Immune Microenvironment to Predict Response to Immunotherapy Plus Chemotherapy in NSCLC. Inamura K. J Thorac Oncol 2023;18:e109-e110.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Inamura K. Exploiting Tumor Immune Microenvironment to Predict Response to Immunotherapy Plus Chemotherapy in NSCLC. J Thorac Oncol 2023;18:e109-e110.
PMID: 37758346